Investigation into the use of histone deacetylase inhibitor MS-275 as a topical agent for the prevention and treatment of cutaneous squamous cell carcinoma in an SKH-1 hairless mouse model-Reference-Cited by-同舟云学术

Investigation into the use of histone deacetylase inhibitor MS-275 as a topical agent for the prevention and treatment of cutaneous squamous cell carcinoma in an SKH-1 hairless mouse model

Published:2019-03-13 Issue:3 Volume:14 Page:e0213095
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kalin Jay H.^ORCID,Eroglu Abdulkerim^ORCID,Liu Hua^ORCID,Holtzclaw W. David,Leigh Irene,Proby Charlotte M.,Fahey Jed W.^ORCID,Cole Philip A.,Dinkova-Kostova Albena T.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. A systematic review of worldwide incidence of nonmelanoma skin cancer;A Lomas;Br J Dermatol,2012

2. Cutaneous squamous cell carcinoma: a review of high-risk and metastatic disease;KA Burton;Am J Clin Dermatol,2016

3. Management of regional metastatic disease in head and neck cutaneous malignancy.1. Cutaneous squamous cell carcinoma;B Gurney;Br J Oral Maxillofac Surg,2014

4. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip;DE Rowe;J Am Acad Dermatol,1992

5. Roles of the immune system in skin cancer;S Rangwala;Br J Dermatol,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unconventional Remedies for Squamous Cell Carcinoma: A Journey into Alternative Treatments;Current Pharmaceutical Biotechnology;2024-12

2. Ex vivo therapeutic screening of metastatic cSCC: A review of methodological considerations for clinical implementation;Experimental Dermatology;2024-04

3. Enhancing MS‐275 Anticancer Activity: Encapsulation of MS‐275 in TPGS Micelles Demonstrated High Efficiency;Journal of Nanotechnology;2024-01

4. UVB Induced Skin Cancer Development in Experimental Mouse Model: A Review;Malaysian Journal of Fundamental and Applied Sciences;2023-10-19

5. Epigenetic drugs as new emerging therapeutics: What is the scale's orientation of application and challenges?;Pathology - Research and Practice;2023-08